EGFR and non-small cell lung carcinoma: 11C-Erlotinib is a PET imaging tracer with great promise for evaluating EGFR expression in NSCLC patients and has been reported in animal models and human subjects, but only a limited number of clinical PET/CT studies have been conducted.